• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

顽固性高血压

Resistant Hypertension.

作者信息

Valsan Debbie, Burhan Umber, Teehan Geoffrey

机构信息

Lankenau Medical Center, Lancaster Avenue, Suite 130, Wynnewood, PA, USA, 19096.

出版信息

Adv Exp Med Biol. 2017;956:181-189. doi: 10.1007/5584_2016_38.

DOI:10.1007/5584_2016_38
PMID:27864800
Abstract

Conservatively, ten million people in the USA alone may suffer from RH and may be similarly prevalent elsewhere. Given the strong linear correlation between hypertension and cardiovascular outcomes, better control is paramount. We favor a multi-pronged approach. It may not suffice to address this by pharmacologic means only. Careful attention to modifiable risk factors, particularly sodium intake, adhering to a proper diet (i.e. DASH), and avoiding agents, i.e. non-steroidals, that can elevate the blood pressure, is key. Frequent follow up to establish the right treatment regimen and home blood pressuring monitoring can have a strong impact on control. Finally, consideration of device therapy may be a more viable option in the future.

摘要

保守估计,仅在美国就有1000万人可能患有难治性高血压(RH),其他地方可能也同样普遍。鉴于高血压与心血管疾病结局之间存在很强的线性相关性,更好地控制血压至关重要。我们赞成采取多管齐下的方法。仅通过药物手段来解决这个问题可能是不够的。密切关注可改变的风险因素,特别是钠的摄入量,坚持合理饮食(即得舒饮食),并避免使用可能升高血压的药物,如非甾体类药物,是关键。频繁随访以确定正确的治疗方案以及家庭血压监测对血压控制会有很大影响。最后,考虑器械治疗在未来可能是一个更可行的选择。

相似文献

1
Resistant Hypertension.顽固性高血压
Adv Exp Med Biol. 2017;956:181-189. doi: 10.1007/5584_2016_38.
2
Device-Based Neuromodulation for Resistant Hypertension Therapy.基于设备的神经调节治疗耐药性高血压。
Circ Res. 2019 Mar 29;124(7):1071-1093. doi: 10.1161/CIRCRESAHA.118.313221.
3
Initial experience with therapeutic geometric modification of the carotid bulb for true resistant hypertension.治疗性颈动脉球部几何形状改造治疗真性难治性高血压的初步经验。
EuroIntervention. 2015 May;11(1):117-20. doi: 10.4244/EIJV11I1A20.
4
Baroreceptor Stimulation for Resistant Hypertension.压力感受器刺激治疗顽固性高血压
Am J Hypertens. 2016 Dec 1;29(12):1319-1324. doi: 10.1093/ajh/hpw074.
5
Emerging concepts for patients with treatment-resistant hypertension.难治性高血压患者的新观念
Trends Cardiovasc Med. 2016 Nov;26(8):700-706. doi: 10.1016/j.tcm.2016.05.004. Epub 2016 May 17.
6
The NEW-HOPE study and emerging therapies for difficult-to-control and resistant hypertension.NEW-HOPE 研究与难治性高血压的新兴治疗方法。
Prog Cardiovasc Dis. 2020 Jan-Feb;63(1):64-73. doi: 10.1016/j.pcad.2019.12.008. Epub 2020 Jan 8.
7
Baroreflex stimulation for treating resistant hypertension: ready for the prime-time?压力反射刺激疗法治疗顽固性高血压:准备好进入黄金时代了吗?
Rev Cardiovasc Med. 2018 Sep 30;19(3):89-95. doi: 10.31083/j.rcm.2018.03.3185.
8
An implantable carotid sinus stimulator for drug-resistant hypertension: surgical technique and short-term outcome from the multicenter phase II Rheos feasibility trial.用于治疗顽固性高血压的植入式颈动脉窦刺激器:多中心II期Rheos可行性试验的手术技术及短期结果
J Vasc Surg. 2006 Dec;44(6):1213-1218. doi: 10.1016/j.jvs.2006.08.024.
9
[Instrumental therapy of drug-resistant hypertension].[耐药性高血压的器械治疗]
Orv Hetil. 2013 Feb 10;154(6):203-8. doi: 10.1556/OH.2013.29543.
10
Resistant Hypertension.顽固性高血压
Adv Clin Exp Med. 2016 Jan-Feb;25(1):173-83. doi: 10.17219/acem/58998.

引用本文的文献

1
Beyond Conventional Control: Insights Into Drug-Resistant Hypertension.超越传统控制:对耐药性高血压的见解
Cureus. 2023 Aug 17;15(8):e43617. doi: 10.7759/cureus.43617. eCollection 2023 Aug.
2
A Randomized, Multicenter, Double-blind, Placebo-Controlled Study to Evaluate the Efficacy and Safety of a Quadruple Combination of Amlodipine, Losartan, Rosuvastatin, and Ezetimibe in Patients with Concomitant Essential Hypertension and Dyslipidemia.一项随机、多中心、双盲、安慰剂对照研究,旨在评估氨氯地平、氯沙坦、瑞舒伐他汀和依折麦布四联组合在同时患有原发性高血压和血脂异常患者中的疗效和安全性。
Am J Cardiovasc Drugs. 2023 Jul;23(4):441-454. doi: 10.1007/s40256-023-00590-9. Epub 2023 Jul 3.
3
Adrenalectomy Improves the Long-Term Risk of End-Stage Renal Disease and Mortality of Primary Aldosteronism.
肾上腺切除术可改善原发性醛固酮增多症患者终末期肾病的长期风险及死亡率。
J Endocr Soc. 2019 Mar 25;3(6):1110-1126. doi: 10.1210/js.2019-00019. eCollection 2019 Jun 1.